Literature DB >> 4078263

Primary malignant tumors of the upper extremity: retrospective analysis of one hundred twenty-six cases.

J J Creighton, C A Peimer, E R Mindell, D C Boone, C P Karakousis, H O Douglass.   

Abstract

We retrospectively evaluated 126 patients with primary sarcomas of bone (45) and soft tissue (61) in the upper extremity principally to evaluate the effectiveness of the Musculoskeletal Tumor Society staging system in predicting treatment outcome and to note differences between bone and soft tissue sarcomas. Patients were followed 2 to 11 years from diagnosis. The mean survival from treatment onset was 49 months (4 to 144 months). A strong statistical relationship (p less than 0.05) between anatomic location (above/below elbow) and surgical stage (stage I/II, A/B) was demonstrated. The type of primary operation and subsequent incidence in local tumor recurrence were found to be statistically different. Seventy percent of soft tissue tumors that metastasized first recurred locally, but such a strong association was not evident for bone. Development of metastases significantly shortened survival. Radical primary excision of soft tissue malignancies sharply reduced local recurrence and thereby diminished metastatic risk; similar findings were not present for bone malignancies. This study suggests that the Musculoskeletal Tumor Society staging system is valid and should be applied to these infrequent malignancies, permitting future statistical comparisons.

Entities:  

Mesh:

Year:  1985        PMID: 4078263     DOI: 10.1016/s0363-5023(85)80155-6

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  9 in total

1.  Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.

Authors:  Krista A Goulding; Adam Schwartz; Steven J Hattrup; R Lor Randall; Donald Lee; Damian M Rispoli; Daniel M Lerman; Christopher Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

2.  The functional and oncological results after scapulectomy for scapular tumours: 2-16-year results.

Authors:  N Mayil Vahanan; P Mohanlal; J C Bose; R Gangadharan; V Karthisundar
Journal:  Int Orthop       Date:  2006-10-17       Impact factor: 3.075

3.  What Factors Influence the Outcome of Surgically Treated Soft Tissue Sarcomas of the Hand and Wrist?

Authors:  Matthew T Houdek; Brian E Walczak; Benjamin K Wilke; Sanjeev Kakar; Peter S Rose; Alexander Y Shin
Journal:  Hand (N Y)       Date:  2016-10-03

4.  Limb sparing surgery for bone tumours of the shoulder girdle: the oncological and functional results.

Authors:  Qiang Yang; Jianmin Li; Zhiping Yang; Xin Li; Zhenfeng Li
Journal:  Int Orthop       Date:  2009-08-23       Impact factor: 3.075

5.  Soft-tissue sarcomas of the shoulder girdle: factors influencing local recurrence distant metastases, and survival.

Authors:  S H Meterissian; J A Reilly; A Murphy; M M Romsdahl; R E Pollock
Journal:  Ann Surg Oncol       Date:  1995-11       Impact factor: 5.344

6.  Malignant tumours of the hand and wrist.

Authors:  Binu P Thomas; Kiran Sasi; Samuel Cr Pallapati; Anil Mathew; R Sreekanth; Meera Thomas
Journal:  Indian J Plast Surg       Date:  2011-05

7.  Management of soft tissue tumors of the upper extremity: a review.

Authors:  Kevin T Jubbal; Gehaan D'Souza; Reid A Abrams; Anna A Kulidjian
Journal:  SICOT J       Date:  2017-06-28

Review 8.  Proximal Humerus Reconstruction after Tumor Resection: An Overview of Surgical Management.

Authors:  Antonio D'Arienzo; Edoardo Ipponi; Alfio Damiano Ruinato; Silvia De Franco; Simone Colangeli; Lorenzo Andreani; Rodolfo Capanna
Journal:  Adv Orthop       Date:  2021-03-19

Review 9.  Implant Survival, Clinical Outcome and Complications of Megaprosthetic Reconstructions Following Sarcoma Resection.

Authors:  Christoph Theil; Jan Schwarze; Georg Gosheger; Burkhard Moellenbeck; Kristian Nikolaus Schneider; Niklas Deventer; Sebastian Klingebiel; George Grammatopoulos; Friedrich Boettner; Tom Schmidt-Braekling
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.